MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas is a research paper published in Frontiers in Oncology (2020). On theSindex it has a DataRank of 0. It has been cited 44 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Japan Society for the Promotion of Science
Grant: 17K16631
Japan Society for the Promotion of Science
Grant: 17K16632
Japan Society for the Promotion of Science
Grant: 17K17739
Japan Society for the Promotion of Science
Grant: 15K10355
Japan Society for the Promotion of Science
Grant: 19K09476
National Institutes of Health
Grant: RO1NS093079
NINDS NIH HHS
Grant: R01 NS093079
National Institutes of Health
Grant: 5R01NS093079-04
Targeting histone demethylase activity for the treatment of pediatric brainstem glioma
Fields of Study
Keywords
Sustainable Development Goals